Guggenheim Capital LLC Adma Biologics, Inc. Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q3 2024
A detailed history of Guggenheim Capital LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 10,778 shares of ADMA stock, worth $187,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,778Holding current value
$187,644% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$325 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$315 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$226 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$220 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$150 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.42B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...